Researcher
Philippe Gevaert
- Disciplines:Allergology, Otorhinolaryngology not elsewhere classified, Rhinology, Sleep medicine, Applied immunology, Immunology not elsewhere classified , Adaptive immunology
Affiliations
- Department of Head and Skin (Department)
Member
From1 Oct 2018 → Today - Department of Otorhinolaryngology (Department)
Responsible
From1 Feb 2014 → 30 Sep 2018 - Department of Otorhinolaryngology (Department)
Member
From1 Feb 2014 → 30 Sep 2018 - Department of Otorhinolaryngology (Department)
Member
From1 Oct 1998 → 30 Sep 2018
Projects
1 - 9 of 9
- Understanding the division of labour between local and systemic humoral responses in allergic airway disease.From1 Jan 2022 → TodayFunding: FWO research project
- An integrated approach to unravel eosinophil function in chronic eosinophilic disordersFrom1 Jan 2022 → TodayFunding: FWO EOS
- CHITINAIR: the role of CHItinases and chitinase like proteins in human Type 2 INflammatory AIRway diseasesFrom1 Nov 2019 → TodayFunding: FWO fellowships
- Mode of action of house dust mite specific immunotherapy.From1 Jan 2014 → 31 Dec 2019Funding: FWO research project
- Food allergy after pediatric liver transplantation: role of the immature immune system and liver in oral toleranceFrom1 Jan 2014 → 31 Dec 2016Funding: FWO research project
- Mode of action of house dust mite specific immunotherapy.From1 Oct 2013 → 30 Sep 2017Funding: FWO fellowships, BOF - Other initiatives
- Diagnostic and therapeutic consequences of mucosal lymphoid accumulation and local IgE in the noseFrom1 Feb 2010 → 30 Sep 2015Funding: BOF - Doctoral projects
- The role of superantigens in local IgE production in the nose.From1 Oct 2007 → 30 Sep 2012Funding: BOF - Other initiatives, FWO fellowships
- The role of superantigens in local IgE production in the noseFrom1 Jan 2007 → 31 Oct 2011Funding: BOF - Doctoral projects
Publications
1 - 10 of 174
- Efficacy and safety of benralizumab in chronic rhinosinusitis with nasal polyps : a randomized, placebo-controlled trial(2022)
Authors: Claus Bachert, Joseph K. Han, Martin Y. Desrosiers, Philippe Gevaert, Enrico Heffler, Claire Hopkins, Jody R. Tversky, Peter Barker, David Cohen, Claire Emson, et al.
Pages: 1309 - 1317.e12 - Novel antibody cocktail targeting Bet v 1 rapidly and sustainably treats birch allergy symptoms in a Phase 1 study(2022)
Authors: Philippe Gevaert, Jarno De Craemer, Natalie De Ruyck, Sylvie Rottey, Jan de Hoon, Peter W. Hellings, Bram Volckaert, Kristof Lesneuck, Jamie M. Orengo, Amanda Atanasio, et al.
Pages: 189 - 199 - Long-term efficacy and safety of omalizumab for nasal polyposis in an open-label extension study(2022)
Authors: Philippe Gevaert, Rebecca Saenz, Jonathan Corren, Joseph K. Han, Joaquim Mullol, Stella E. Lee, Randall A. Ow, Rui Zhao, Monet Howard, Kit Wong, et al.
Pages: 957 - 965.e3 - COVIDU+201019 vaccination with BNT162b2 and ChAdOx1 vaccines has the potential to induce nasal neutralizing antibodies(2022)
Authors: Jozefien Declercq, Els Tobback, Stijn Vanhee, Natalie De Ruyck, Sarah Gerlo, Philippe Gevaert, Linos Vandekerckhove
Pages: 304 - 307 - The role of IgE in upper and lower airway disease : more than just allergy!(2022)
Authors: Philippe Gevaert, Kit Wong, Lauren A. Millette, Tara F. Carr
Pages: 200 - 215 - EUFOREA expert board meeting on uncontrolled severe chronic rhinosinusitis with nasal polyps (CRSwNP) and biologics : definitions and management(2021)
Authors: Claus Bachert, Joe K. Han, Martin Wagenmann, Werner Hosemann, Stella E. Lee, Vibeke Backer, Joaquim Mullol, Philippe Gevaert, Ludger Klimek, Emanuel Prokopakis, et al.
Pages: 29 - 36 - ARIA digital anamorphosis : digital transformation of health and care in airway diseases from research to practice(2021)
Authors: Jean Bousquet, Josep M. Anto, Claus Bachert, Tari Haahtela, Torsten Zuberbier, Wienczyslawa Czarlewski, Anna Bedbrook, Sinthia Bosnic-Anticevich, G. Walter Canonica, Victoria Cardona, et al.
Pages: 168 - 190 - Personalized medicine for allergy treatment : allergen immunotherapy still a unique and unmatched model(2021)
Authors: Cristoforo Incorvaia, Mona Al-Ahmad, Ignacio J. Ansotegui, Stefania Arasi, Claus Bachert, Catherine Bos, Jean Bousquet, Andrzej Bozek, Davide Caimmi, Moises A. Calderon, et al.
Pages: 1041 - 1052 - Dupilumab provides early and durable improvement of symptoms in patients with chronic rhinosinusitis with nasal polyps : results from the SINUS-24 and SINUS-52 phase 3 trials(2021)Volume: 203
Authors: Philippe Gevaert, SE Lee, R Settipane, M Wagenmann, J Msihid, S Siddiqui, S Nash, JA Jacob-Nara, Asif Hameed Khan, S Kamat, et al.
Pages: A1341 - A1341 - Dupilumab reduces systemic corticosteroid use and sinonasal surgery rate in CRSwNP(2021)
Authors: M. Desrosiers, L.P. Mannent, N. Amin, G.W. Canonica, Peter Hellings, Philippe Gevaert, J. Mullol, S.E. Lee, S. Fujieda, J.K. Han, et al.
Pages: 301 - 311